Humana (HUM) to Release Earnings on Wednesday

Humana (NYSE:HUM) is expected to announce its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect the company to announce earnings of ($4.01) per share and revenue of $32.0804 billion for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Wednesday, February 11, 2026 at 8:00 AM ET.

Humana Stock Performance

Shares of Humana stock opened at $193.91 on Monday. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The stock’s fifty day moving average price is $251.55 and its 200-day moving average price is $263.04. The firm has a market cap of $23.32 billion, a P/E ratio of 18.17, a P/E/G ratio of 1.61 and a beta of 0.44. Humana has a 12 month low of $186.00 and a 12 month high of $315.35.

Analyst Upgrades and Downgrades

A number of research analysts have commented on HUM shares. Truist Financial cut their target price on shares of Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. Jefferies Financial Group cut their price objective on shares of Humana from $313.00 to $310.00 and set a “buy” rating on the stock in a report on Monday, January 26th. Wolfe Research boosted their price objective on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, January 8th. Wells Fargo & Company cut Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Finally, Robert W. Baird reduced their price target on Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, Humana currently has an average rating of “Hold” and a consensus price target of $293.21.

Institutional Trading of Humana

A number of institutional investors have recently made changes to their positions in HUM. Larson Financial Group LLC raised its stake in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the last quarter. Fulcrum Asset Management LLP acquired a new position in shares of Humana during the third quarter valued at about $42,000. BOKF NA raised its position in shares of Humana by 4,125.0% in the 3rd quarter. BOKF NA now owns 169 shares of the insurance provider’s stock valued at $44,000 after purchasing an additional 165 shares during the last quarter. Geneos Wealth Management Inc. boosted its stake in Humana by 40.3% in the 2nd quarter. Geneos Wealth Management Inc. now owns 571 shares of the insurance provider’s stock worth $140,000 after purchasing an additional 164 shares in the last quarter. Finally, Sunbelt Securities Inc. grew its position in Humana by 18.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 719 shares of the insurance provider’s stock worth $187,000 after purchasing an additional 110 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.